Articles

State slow to move to money-saving home health care

Indiana taxpayers are paying about $300 million a year in nursing home costs despite a state law that would allow the state to save millions while keeping many elderly and disabled Hoosiers in their homes or with family members.

Read More

Roche wins approval of HPV test

Roche Diagnostics Corp. won regulatory approval for a new HPV test, giving it a technological edge in the $300 million market for automated cervical cancer tests.

Read More

Anthem: Global payments coming back

Anthem Blue Cross and Blue Shield’s vision for accountable care organizations foresees doctors and hospitals shifting to global capitation payments and employers getting bigger discounts if they allow their workers access only to health care providers in a specific organization.

Read More

Q&A

Paul Leamon launched Wellfount Corp. five years ago to help long-term-care facilities automate and electronically manage their pharmacies. Wellfount made the Inc. 500 list last year and now has secured $6 million in venture capital from Arboretum Ventures to help it expand nationally.

Read More

Insurer coveted by Biglari sold to another firm

Steak n Shake's parent company, Biglari Holdings, twice tried to acquire Fremont Michigan Insuracorp Inc. before the insurer agreed to be sold to Michigan-based Auto Club Insurance Association. Biglari, which owns nearly 10 percent of the insurer's shares, nevertheless was a winner in the sale.

Read More

Much unknown about new Cook Group CEO

Carl Cook has been tabbed to replace his father, Bill Cook, who died a week ago. But many in the Bloomington business community know little about him, which reflects the company’s strict privacy policy.

Read More

Analysts demand news on next Lilly blockbuster

Eli Lilly and Co. spends a lot of time these days telling the rest of the story—how well it’s doing in areas not connected to highly lucrative drugs about to see their patents expire. But for the most part, investors and analysts just want to know when the next blockbuster will be coming.

Read More

Charges drive down first-quarter profit at Lilly

First-quarter profit fell at Eli Lilly and Co. as the company recorded restructuring charges due to its downsizing and higher research costs as it tries to develop new drugs to help it shrug off its looming patent expirations.

Read More